sdf
@sdfhfnjjjjjjjjjj
The White House hopes a new cash-pay platform for popular GLP-1 drugs will lower U.S. prices. It aims to pressure drug companies and cut out the middlemen. This direct approach could make treatments more affordable.
0 reply
0 recast
0 reaction